Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 93

Sort by

Sort Order Select

Journal Articles

Identification of Novel Synthetic Lethal Partners of NAMPT Inhibitor By CRISPR-Cas9 Screens in Acute Myeloid Leukemia

Pu Zhang, Lindsey Brinton, PhD, James S. Blachly, MD, John C. Byrd, MD, Rosa Lapalombella, PhD

Blood (2019) 134 (Supplement_1): 2072.

https://doi.org/10.1182/blood-2019-129036

Published: 2019

Journal Articles

Cryo-Electron Microscopy Structure of the aIIbβ3-Abciximab Complex

Dragana Nesic, PhD, Yixiao Zhang, PhD, Aleksandar Spasic, PhD, Jihong Li, MD, Davide Provasi, PhD, Marta Filizola, PhD, Thomas Walz, PhD, Barry S. Coller, MD

Blood (2019) 134 (Supplement_1): 3617.

https://doi.org/10.1182/blood-2019-126985

Published: 2019

Journal Articles

Net Clinical Benefit of Low Dose Rivaroxaban in Coronary Heart Disease: A Systematic Review and Meta-Analysis

Muhammad Zain Farooq, MD MBBS, Muhammad Saad Farooq, MBBS, Saira Farid, MD, Talha Aijaz, MD, Ishaan Vohra, MD, Vatsala Katiyar, MD, Ankit Mangla, MBBS,MD

Blood (2019) 134 (Supplement_1): 3662.

https://doi.org/10.1182/blood-2019-121899

Published: 2019

Journal Articles

A Quantitative Systems Pharmacology (QSP) Model to Predict Receptor Occupancy of Bruton's Tyrosine Kinase (BTK) Inhibitors in Peripheral Blood Mononuclear Cells, Bone Marrow and Lymph Nodes of Patients with B-Cell Malignancies

Srikumar Sahasranaman, PhD, Oleg Demin, Jr., Dmitry Shchelokov, Veronika Musatova, Nageshwar Budha, PhD, Ying Ou, PhD

Blood (2019) 134 (Supplement_1): 1289.

https://doi.org/10.1182/blood-2019-129133

Published: 2019

Journal Articles

HDAC8 Maintain Cytoskeleton Integrity Via Homologous Recombination and Represent a Novel Therapeutic Target in Multiple Myeloma

Zuzana Chyra, PhD, Maria Gkotzamanidou, MD PhD, Masood A. Shammas, PhD, Vassilis L. Souliotis, PhD, Yan Xu, MD, Mehmet K. Samur, PhD, Aaron B. Beeler, PhD, Roman Hajek, MD, Mariateresa Fulciniti, PhD, Nikhil C. Munshi, MD

Blood (2019) 134 (Supplement_1): 4385.

https://doi.org/10.1182/blood-2019-130700

Published: 2019

Journal Articles

Comparison of New Oral Anticoagulants (NOAC) Based Double Therapy Versus Vitamin K Antagonist Based Triple Therapy in Patients Undergoing Percutaneous Coronary Intervention with Atrial Fibrillation: A Systematic Review and Meta-Analysis

Muhammad Zain Farooq, MD MBBS, Prasanth Lingamaneni, Muhammad Saad Farooq, MBBS, Aakash Putta, MD MBBS, Sheeba Ba Aqeel, VV Pavan Kedar Mukthinuthalapati, Ankit Mangla, MBBS, MD, Paul Rubinstein, MD

Blood (2019) 134 (Supplement_1): 4963.

https://doi.org/10.1182/blood-2019-129607

Published: 2019

Journal Articles

Study on the Possibility of Emergency Percutaneous Coronary Intervention (PCI) in Myeloproliferative Neoplasms (MPNs) Patients with Acute Coronary Syndrome (ACS)

Ye Chen, Xiuchuan Qin, Xue Han, Beibei Bai, Yingchun Wang

Blood (2019) 134 (Supplement_1): 5375.

https://doi.org/10.1182/blood-2019-124612

Published: 2019

Journal Articles

Aptamers as Rapid Onset and Rapidly Reversible Antithrombotic Agents

Bruce A. Sullenger, PhD

Blood (2019) 134 (Supplement_1): SCI-16.

https://doi.org/10.1182/blood-2019-121056

Published: 2019

Journal Articles

A Multi-Center Quality Improvement Intervention to Reduce the Inappropriate Use of Aspirin Among Patients Anticoagulated with Warfarin for Atrial Fibrillation or Venous Thromboembolism

Jordan K Schaefer, MD, Josh Errickson, PhD, Xiaokui Gu, MA, Tina Alexandris-Souphis, RN, Mona A Ali, PharmD, Brian Haymart, RN, MS, Scott Kaatz, DO, MSc, Eva Kline-Rogers, RN, MS, Jay H Kozlowski, MD, Gregory D Krol, Suman L Sood, MD, James B Froehlich, MD MPH, Geoffrey D Barnes, MD MSc

Blood (2019) 134 (Supplement_1): 788.

https://doi.org/10.1182/blood-2019-123067

Published: 2019

Journal Articles

Impact of Adding Aspirin to Direct Oral Anticoagulant Therapy without an Apparent Indication

Jordan K Schaefer, MD, Yun Li, PhD, Xiaowen Kong, MA, Tina Alexandris-Souphis, RN, Mona A Ali, PharmD, Brian Haymart, RN, MS, Scott Kaatz, DO, MSc, Eva Kline-Rogers, RN, MS, Jay H Kozlowski, MD, Gregory D Krol, Sahana R Shankar, Suman L Sood, MD, James B Froehlich, MD MPH, Geoffrey D Barnes, MD MSc

Blood (2019) 134 (Supplement_1): 787.

https://doi.org/10.1182/blood-2019-122526

Published: 2019

Journal Articles

A Direct Oral Anticoagulant Edoxaban Enhanced Fibrinolysis Via Inhibition of Thrombin-Activatable Fibrinolysis Inhibitor Activation and Enhancement of Plasmin Generation in Human Plasma

Yoshiyuki Morishima, PhD, Yuko Honda, Taketoshi Furugohri, PhD

Blood (2018) 132 (Supplement 1): 3786.

https://doi.org/10.1182/blood-2018-99-109724

Published: 2018

Journal Articles

Neutrophil Extracellular Traps Promote Hypercoagulability in ST-Elevated Myocardial Infarction Following Fibrinolytic Administration

Lili Zou, MD, Hui Liang, MD, LI Hou, MD, Tao Li, MD, Yan Zhang, MD, Baorong LI, MD, Yingmiao LIU, MD, Cong Zhang, MD, Yan Kou, MD, Xinyi Zhao, MD, Ruipeng Liu, MD, Ying Wang, MD, Peng Zhou, MD, Yayan Bi, MD PhD, Jialan Shi, MD PhD, Junjie Kou, MD PhD

Blood (2018) 132 (Supplement 1): 3797.

https://doi.org/10.1182/blood-2018-99-116105

Published: 2018

Journal Articles

Antiplatelet Therapy for Patients with Hemophilia after Percutaneous Coronary Intervention

Peter Xie, MD, Devin Malik, MD, Philip Kuriakose, MD

Blood (2018) 132 (Supplement 1): 5041.

https://doi.org/10.1182/blood-2018-99-114296

Published: 2018

Journal Articles

Rivaroxaban Thromboprophylaxis in High-Risk Ambulatory Cancer Patients Receiving Systemic Therapy: Results of a Randomized Clinical Trial (CASSINI)

Blood (2018) 132 (Supplement 1): LBA-1.

https://doi.org/10.1182/blood-2018-120738

Published: 2018

Journal Articles

Antithrombotic Therapy Management in Patients with Inherited Bleeding Disorders and Ischaemic Heart Disease: A Single-Center Experience

Marie-Léa Piel-Julian, Marie-Françoise Thiercelin-Legrand, MD, Guillaume Moulis, MD PhD, Sophie Voisin, MD, Ségolène Claeyssens, Laurent Sailler, MD PhD

Blood (2018) 132 (Supplement 1): 1213.

https://doi.org/10.1182/blood-2018-99-117101

Published: 2018

Journal Articles

Restrictive Versus Liberal Red Blood Cell Transfusion for Cardiac Surgery: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

Babikir Kheiri, MD, Ahmed Abdalla, MD, Mohamed Osman, MD, Tarek Haykal, MD, Sai Chintalapati, MD, James Cranford, PhD, Sahar Ahmed, MBBS, Mustafa Hassan, MD, Ghassan Bachuwa, MD MHSA, MS, Deepak L. Bhatt, MD MPH

Blood (2018) 132 (Supplement 1): 3821.

https://doi.org/10.1182/blood-2018-99-111993

Published: 2018

Journal Articles

Integrated Safety Results from the Phase II and Phase III Studies with Caplacizumab in Patients with Acquired Thrombotic Thrombocytopenic Purpura

Paul Knöbl, MD PhD, Marie Scully, MD MRCP, FRCPath, Spero R Cataland, MD, Flora Peyvandi, MD PhD, Paul Coppo, MD PhD, Johanna A. Kremer Hovinga, MD Prof, Ara Metjian, MD, Javier De La Rubia, MD, Katerina Pavenski, MD, Jessica Minkue, Filip Callewaert, PhD, Hilde De Winter, MD

Blood (2018) 132 (Supplement 1): 3739.

https://doi.org/10.1182/blood-2018-99-112174

Published: 2018

Journal Articles

Histone Deacetylase Inhibitors Downregulate CCR4 Expression and Decrease Mogamulizumab Efficacy in CCR4-Positive Mature T-Cell Lymphomas

Akihiro Kitadate, MD, Sho Ikeda, MD, Fumito Abe, MD PhD, Naoto Takahashi, MD PhD, Norio Shimizu, PhD, Kosei Matsue, MD PhD, Hiroyuki Tagawa, MD PhD

Blood (2017) 130 (Supplement 1): 720.

https://doi.org/10.1182/blood.V130.Suppl_1.720.720

Published: 2017

Journal Articles

Phenotype Does Not Always Equal Function: HDAC Inhibitors and UM171, but Not SR1, Lead to Rapid Upregulation of CD90 on Non-Engrafting CD34+CD90-Negative Human Cells

Kevin A. Goncalves, PhD, Megan D. Hoban, Jennifer L. Proctor, BS, Hillary L. Adams, MS, Sharon L. Hyzy, MS, Anthony E. Boitano, PhD, Michael P. Cooke, PhD

Blood (2017) 130 (Supplement 1): 659.

https://doi.org/10.1182/blood.V130.Suppl_1.659.659

Published: 2017

Journal Articles

The Impact of Adding Aspirin to Warfarin without an Apparent Indication: An Exploration of Patients Anticoagulated for Atrial Fibrillation or Venous Thromboembolic Disease

Jordan K. Schaefer, MD, Nicole M. Souphis, Suman L. Sood, MD MSCE, Brian Haymart, RN, MS, Xiaokui Gu, MA, Eva Kline-Rogers, RN, MS, Steven L. Almany, MD, Jay H. Kozlowski, MD, Gregory D. Krol, MD, Scott Kaatz, DO, MSc, James B. Froehlich, MD MPH, Geoffrey D. Barnes, MD MSc

Blood (2017) 130 (Supplement 1): 220.

https://doi.org/10.1182/blood.V130.Suppl_1.220.220

Published: 2017

NARROW

Identification of Novel Synthetic Lethal Partners of NAMPT Inhibitor By CRISPR-Cas9 Screens in Acute Myeloid Leukemia

Cryo-Electron Microscopy Structure of the aIIbβ3-Abciximab Complex

Net Clinical Benefit of Low Dose Rivaroxaban in Coronary Heart Disease: A Systematic Review and Meta-Analysis

A Quantitative Systems Pharmacology (QSP) Model to Predict Receptor Occupancy of Bruton's Tyrosine Kinase (BTK) Inhibitors in Peripheral Blood Mononuclear Cells, Bone Marrow and Lymph Nodes of Patients with B-Cell Malignancies

HDAC8 Maintain Cytoskeleton Integrity Via Homologous Recombination and Represent a Novel Therapeutic Target in Multiple Myeloma

Comparison of New Oral Anticoagulants (NOAC) Based Double Therapy Versus Vitamin K Antagonist Based Triple Therapy in Patients Undergoing Percutaneous Coronary Intervention with Atrial Fibrillation: A Systematic Review and Meta-Analysis

Study on the Possibility of Emergency Percutaneous Coronary Intervention (PCI) in Myeloproliferative Neoplasms (MPNs) Patients with Acute Coronary Syndrome (ACS)

Aptamers as Rapid Onset and Rapidly Reversible Antithrombotic Agents

A Multi-Center Quality Improvement Intervention to Reduce the Inappropriate Use of Aspirin Among Patients Anticoagulated with Warfarin for Atrial Fibrillation or Venous Thromboembolism

Impact of Adding Aspirin to Direct Oral Anticoagulant Therapy without an Apparent Indication

A Direct Oral Anticoagulant Edoxaban Enhanced Fibrinolysis Via Inhibition of Thrombin-Activatable Fibrinolysis Inhibitor Activation and Enhancement of Plasmin Generation in Human Plasma

Neutrophil Extracellular Traps Promote Hypercoagulability in ST-Elevated Myocardial Infarction Following Fibrinolytic Administration

Antiplatelet Therapy for Patients with Hemophilia after Percutaneous Coronary Intervention

Rivaroxaban Thromboprophylaxis in High-Risk Ambulatory Cancer Patients Receiving Systemic Therapy: Results of a Randomized Clinical Trial (CASSINI)

Antithrombotic Therapy Management in Patients with Inherited Bleeding Disorders and Ischaemic Heart Disease: A Single-Center Experience

Restrictive Versus Liberal Red Blood Cell Transfusion for Cardiac Surgery: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

Integrated Safety Results from the Phase II and Phase III Studies with Caplacizumab in Patients with Acquired Thrombotic Thrombocytopenic Purpura

Histone Deacetylase Inhibitors Downregulate CCR4 Expression and Decrease Mogamulizumab Efficacy in CCR4-Positive Mature T-Cell Lymphomas

Phenotype Does Not Always Equal Function: HDAC Inhibitors and UM171, but Not SR1, Lead to Rapid Upregulation of CD90 on Non-Engrafting CD34+CD90-Negative Human Cells

The Impact of Adding Aspirin to Warfarin without an Apparent Indication: An Exploration of Patients Anticoagulated for Atrial Fibrillation or Venous Thromboembolic Disease

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only